| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| PROFESSIONAL FEES | 3,700 | 3,700 | 0 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| 200 MURPHY OIL | AT COST | 1,452 | 4,490 |
| 100 AMGEN | AT COST | 2,012 | 16,233 |
| 35 IBM | AT COST | 0 | 0 |
| 1500 SAPIENT CORP | AT COST | 0 | 0 |
| 125 JOHNSON & JOHNSON | AT COST | 5,921 | 8,731 |
| 50 REGENERON PHARMACEUTICALS | AT COST | 3,101 | 10,857 |
| 200 DISCOVERY COMMUNICATIONS INC SER A | AT COST | 0 | 0 |
| 125 EOG RES INC | AT COST | 5,732 | 7,079 |
| 125 GILEAD SCIENCES INC | AT COST | 4,583 | 4,554 |
| 500 ENTERPRISE PRODUCTS PARTNERS LP | AT COST | 7,012 | 5,116 |
| 150 DISCOVERY COMMUNICATIONS INC SER C | AT COST | 0 | 3,783 |
| Description | Beginning of Year - Book Value | End of Year - Book Value | End of Year - Fair Market Value |
|---|---|---|---|
| MISCELLANEOUS RECEIVABLE | 6,595 | 0 | 0 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| INVESTMENT FEES | 1,004 | 1,004 | 0 | |
| FEDERAL TAX | 2,000 | 0 | 0 |